Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Medical Imaging Software Market

ID: MRFR/MED/17877-HCR
100 Pages
Rahul Gotadki
March 2026

US Medical Imaging Software Market Research Report: Size, Share, Trend Analysis By Software Type (Integrated, Stand-Alone), By Imaging Type (2D, 3D, 4D), By Modality (CT, MRI) and By Applications (Neurology, Cardiology) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Medical Imaging Software Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Construction, BY Application (USD Million)
  49.     4.1.1 Radiology
  50.     4.1.2 Cardiology
  51.     4.1.3 Oncology
  52.     4.1.4 Orthopedics
  53.   4.2 Construction, BY Deployment Type (USD Million)
  54.     4.2.1 On-Premise
  55.     4.2.2 Cloud-Based
  56.     4.2.3 Web-Based
  57.   4.3 Construction, BY End User (USD Million)
  58.     4.3.1 Hospitals
  59.     4.3.2 Diagnostic Centers
  60.     4.3.3 Research Institutes
  61.     4.3.4 Pharmaceutical Companies
  62.   4.4 Construction, BY Imaging Modality (USD Million)
  63.     4.4.1 Ultrasound Imaging
  64.     4.4.2 Computed Tomography
  65.     4.4.3 Magnetic Resonance Imaging
  66.     4.4.4 X-Ray Imaging
  67. 5 SECTION V: COMPETITIVE ANALYSIS
  68.   5.1 Competitive Landscape
  69.     5.1.1 Overview
  70.     5.1.2 Competitive Analysis
  71.     5.1.3 Market share Analysis
  72.     5.1.4 Major Growth Strategy in the Construction
  73.     5.1.5 Competitive Benchmarking
  74.     5.1.6 Leading Players in Terms of Number of Developments in the Construction
  75.     5.1.7 Key developments and growth strategies
  76.       5.1.7.1 New Product Launch/Service Deployment
  77.       5.1.7.2 Merger & Acquisitions
  78.       5.1.7.3 Joint Ventures
  79.     5.1.8 Major Players Financial Matrix
  80.       5.1.8.1 Sales and Operating Income
  81.       5.1.8.2 Major Players R&D Expenditure. 2023
  82.   5.2 Company Profiles
  83.     5.2.1 Siemens Healthineers (DE)
  84.       5.2.1.1 Financial Overview
  85.       5.2.1.2 Products Offered
  86.       5.2.1.3 Key Developments
  87.       5.2.1.4 SWOT Analysis
  88.       5.2.1.5 Key Strategies
  89.     5.2.2 GE Healthcare (US)
  90.       5.2.2.1 Financial Overview
  91.       5.2.2.2 Products Offered
  92.       5.2.2.3 Key Developments
  93.       5.2.2.4 SWOT Analysis
  94.       5.2.2.5 Key Strategies
  95.     5.2.3 Philips Healthcare (NL)
  96.       5.2.3.1 Financial Overview
  97.       5.2.3.2 Products Offered
  98.       5.2.3.3 Key Developments
  99.       5.2.3.4 SWOT Analysis
  100.       5.2.3.5 Key Strategies
  101.     5.2.4 Canon Medical Systems (JP)
  102.       5.2.4.1 Financial Overview
  103.       5.2.4.2 Products Offered
  104.       5.2.4.3 Key Developments
  105.       5.2.4.4 SWOT Analysis
  106.       5.2.4.5 Key Strategies
  107.     5.2.5 Agfa HealthCare (BE)
  108.       5.2.5.1 Financial Overview
  109.       5.2.5.2 Products Offered
  110.       5.2.5.3 Key Developments
  111.       5.2.5.4 SWOT Analysis
  112.       5.2.5.5 Key Strategies
  113.     5.2.6 Fujifilm Medical Systems (JP)
  114.       5.2.6.1 Financial Overview
  115.       5.2.6.2 Products Offered
  116.       5.2.6.3 Key Developments
  117.       5.2.6.4 SWOT Analysis
  118.       5.2.6.5 Key Strategies
  119.     5.2.7 Hologic (US)
  120.       5.2.7.1 Financial Overview
  121.       5.2.7.2 Products Offered
  122.       5.2.7.3 Key Developments
  123.       5.2.7.4 SWOT Analysis
  124.       5.2.7.5 Key Strategies
  125.     5.2.8 Carestream Health (US)
  126.       5.2.8.1 Financial Overview
  127.       5.2.8.2 Products Offered
  128.       5.2.8.3 Key Developments
  129.       5.2.8.4 SWOT Analysis
  130.       5.2.8.5 Key Strategies
  131.     5.2.9 Mindray (CN)
  132.       5.2.9.1 Financial Overview
  133.       5.2.9.2 Products Offered
  134.       5.2.9.3 Key Developments
  135.       5.2.9.4 SWOT Analysis
  136.       5.2.9.5 Key Strategies
  137.   5.3 Appendix
  138.     5.3.1 References
  139.     5.3.2 Related Reports
  140. 6 LIST OF FIGURES
  141.   6.1 MARKET SYNOPSIS
  142.   6.2 US MARKET ANALYSIS BY APPLICATION
  143.   6.3 US MARKET ANALYSIS BY DEPLOYMENT TYPE
  144.   6.4 US MARKET ANALYSIS BY END USER
  145.   6.5 US MARKET ANALYSIS BY IMAGING MODALITY
  146.   6.6 KEY BUYING CRITERIA OF CONSTRUCTION
  147.   6.7 RESEARCH PROCESS OF MRFR
  148.   6.8 DRO ANALYSIS OF CONSTRUCTION
  149.   6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
  150.   6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
  151.   6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
  152.   6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
  153.   6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
  154.   6.14 CONSTRUCTION, BY DEPLOYMENT TYPE, 2024 (% SHARE)
  155.   6.15 CONSTRUCTION, BY DEPLOYMENT TYPE, 2024 TO 2035 (USD Million)
  156.   6.16 CONSTRUCTION, BY END USER, 2024 (% SHARE)
  157.   6.17 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
  158.   6.18 CONSTRUCTION, BY IMAGING MODALITY, 2024 (% SHARE)
  159.   6.19 CONSTRUCTION, BY IMAGING MODALITY, 2024 TO 2035 (USD Million)
  160.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  161. 7 LIST OF TABLES
  162.   7.1 LIST OF ASSUMPTIONS
  163.     7.1.1
  164.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  165.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  166.     7.2.2 BY DEPLOYMENT TYPE, 2025-2035 (USD Million)
  167.     7.2.3 BY END USER, 2025-2035 (USD Million)
  168.     7.2.4 BY IMAGING MODALITY, 2025-2035 (USD Million)
  169.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  170.     7.3.1
  171.   7.4 ACQUISITION/PARTNERSHIP
  172.     7.4.1

US Construction Market Segmentation

Construction By Application (USD Million, 2025-2035)

  • Radiology
  • Cardiology
  • Oncology
  • Orthopedics

Construction By Deployment Type (USD Million, 2025-2035)

  • On-Premise
  • Cloud-Based
  • Web-Based

Construction By End User (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Pharmaceutical Companies

Construction By Imaging Modality (USD Million, 2025-2035)

  • Ultrasound Imaging
  • Computed Tomography
  • Magnetic Resonance Imaging
  • X-Ray Imaging

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions